Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-03-02 00:00:00 ET · period of report 2026-02-26 · accession 0001946439-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-02-26 | ANIP | Davis Krista | SVP, Chief HR Off | A - Grant | $77.15 | +10.8K | 60.1K | +22% | +$834.0K | |
| 2026-03-02 | 2026-02-28 | ANIP | Davis Krista | SVP, Chief HR Off | F - Tax | $73.90 | -1,555 | 58.5K | -3% | -$114.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-26 | A | A | 10,810 | $77.15 | 60,073 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-28 | F | D | 1,555 | $73.90 | 58,518 | D | — | — |